ESGCT e-Seminar: Combining Oncolytic Viruses and CAR-T Therapies Published 2022-02-15 Download video MP4 360p Recommendations 57:37 Engineered T Cells for Cancer 1:22:28 THE HUMAN MICROBIOME: A New Frontier in Health 1:03:49 A 2023 Update on CAR-T Therapy in Myeloma with Dr. Craig Hofmeister 30:01 Basics of AAV Gene Therapy 40:38 Therapeutic T cell engineering: CD19 CAR therapy and beyond 1:56:10 Sunlight: Optimize Health and Immunity (Light Therapy and Melatonin) 1:32:16 An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar 27:43 HIV/AIDS: Spotlight on Stem Cell Research - John Zaia 55:10 CAR-T Cell Therapy: Now and in 2030 | Laboratory Medicine and Pathology in Individualized Medicine 2:03:10 City of Hope | Ask the Experts - Prostate Cancer: What You Need to Know 3:46:20 Copy of Stomach Cancer Patient Empowerment Summit 26:36 T Cell Activation and Control 1:09:19 Cancer immunotherapy - significant breakthrough or unrealised potential? 1:01:36 Deciphering CAR-T Cells: Exploring Functional Mechanisms to Drive Next Generation Immunotherapy 41:06 What is Cervical Stenosis? | Jeffrey Cantor, MD 1:03:37 CTSI Distinguished Speaker Series I Yvonne Chen 29:51 How Stem Cells Contribute to Aging and Age-Related Diseases with Rob Signer 59:27 Updates in CAR T Cell Therapies 1:21:35 Immunotherapy 2023/2024 45:39 City of Hope | Ask the Experts - Colon Health Similar videos 56:11 ESGCT e-Seminar: Virus-free gene editing of T cells 52:11 ESGCT e-School: Cancer immunotherapy: beyond CAR T cells 55:30 ESGCT e-Seminar: Considerations for engineering allogeneic cell therapies 07:21 Oncolytic Virotherapy 1:01:27 ESGCT e-School: Gene Therapy – From Concept to Proof 47:26 ESGCT e-School: Adenoviral vectors – gene delivery tool, powerful weapon in cancer and beyond 1:14:51 ESGCT e-School: Learn from viruses to improve viral and non-viral vectors 21:23 Oncolytic Virotherapy and Angiogenesis Inhibitors for Skull Base Tumors 45:22 ASGCT 2021 Presidential Symposium: Robert L. Martuza, M.D. 01:54 Oncolytic viruses as a promising therapeutic strategy for cancer 00:22 ChemoMetec 16:12 A clinical stage immuno-oncology company. 22:33 Fueling Antitumor Immunity Using Oncolytic Viruses Encoding Metabolic Modulators 02:57 Adapting cell therapies to solid tumors 1:27:54 Going viral: Examining advancements in oncolytic viral therapies and their future 32:52 Oncolytic Viral Therapy - Timothy Qi 01:02 The use of CAR-T cell products in a real-world setting 1:04:14 ESGCT e-School: Lysosomal storage diseases - gene therapy as treatment option More results